S&P August Winners and Losers: Kellanova Tops Index After Turbulent Month, SMCI Plunges
Market Whales and Their Recent Bets on ALNY Options
Alnylam Tumbles, BridgeBio Gains After Heart Drug Data
Judge's Early Ruling May Shape Outcome In Ozempic, Wegovy Lawsuits
Alnylam Pharmaceuticals Analyst Ratings
Why Is BridgeBio Pharma Stock Trading Higher On Friday?
BridgeBio Shares Data On Serum TTR Increase When Switching Participants From Placebo And Tafamidis To Acoramidis In ATTRibute-CM And Its Open-Label Extension; Showed A 42% Reduction In Composite CVH And ACM, And A 50% Reduction In The Cumulative...
Marvell Technology Posts Upbeat Sales, Joins MongoDB, Intel, MINISO Group And Other Big Stocks Moving Higher On Friday
Novo Nordisk Touts Encouraging Wegovy Data To Lower Risk Of Severe Complications In Heart Failure Patients
Alnylam Says Typo In Presentation Misstated Heart Drug Benefit
Alnylam Pharmaceuticals Shares Are Trading Lower. The Company Announced Results From Its HELIOS-B Phase 3 Study of Vutrisiran, an Investigational RNAi Therapeutic in Development for the Treatment of ATTR Amyloidosis With Cardiomyopathy.
Alnylam Falls After Full Data for Heart Drug That Can Rival Pfizer's
Amgen Unusual Options Activity For August 29
Health Care, 3 Other S&P Sectors at All-time Highs as Index Edges Closer to Fresh Peak
Vertex Pharmaceuticals's Options Frenzy: What You Need to Know
J&J Submits FDA Application for Myasthenia Gravis Drug Nipocalimab
Decoding Eli Lilly's Options Activity: What's the Big Picture?
Intuit, Amgen And Sprott Uranium Miners ETF: CNBC's 'Final Trades'
Jim Cramer: 'Hold On' To Builders FirstSource, 'Here's The Problem' With Viking Therapeutics
Tsinghua University's president has served as the chief scientist. Pinchi Medical has initiated IPO counseling, with investment from Gao Ling, Eli Lilly and Junlian.
1. Healthily Medical has initiated IPO counseling, with China International Capital Corporation as the consulting institution; 2. Healthily Medical's neuroregulation products such as brain pacemakers have broken the monopoly in the United States; 3. Healthily Medical's planned listing sector may be the STAR board.